DR. SHEREEF HILMY II
MEET
DR. SHEREEF HILMY II
Cardiologist
Dr. Hilmy is a board-certified interventional cardiologist with extensive experience in multiple cardiac sub-specialties. He is a graduate of All India Institute Of Medical Sciences. He completed his post-graduate medical training at New York Medical College, Valhalla, New York. His training at that institution included a medical internship, medical residency, general cardiology, and interventional cardiology. He also sewed as the Chief Medical Resident and Instructor of Medicine at the same institution.
Dr. Blake and Dr. Hilmy were the founders of the Heart Clinic group, an organization that revolutionized cardiology practice in the Rio Grande Valley. Dr. Hilmy was involved in initiating multiple programs for cardiac care since his arrival in the Rio Grande Valley. Some of these programs include:
Coronary angioplasty
Coronary stenting
Peripheral artery disease therapy
Nuclear cardiology
Coronary and peripheral atherectomy
Trans-esophageal echocardiography
Carotid artery angioplasty and stenting
Cardiac Pacemaker and Defibrillator implant, including Biventricular Pacemakers and Defibrillators
Dr. Hilmy was the principal investigator for the SAPPHIRE WORLDWIDE TRIAL in the Rio Grande Valley.
Dr. Hilmy is board certified in the specialty of Internal Medicine, the sub-specialty of Cardiovascular Diseases, and NASPE/HRS electrophysiology Certified Cardiac Device Management. He is a fellow of the American College of Cardiology, Fellow of the American College of Chest Physicians, Fellow of the Society of Cardiac Angiography and Interventions, a Member of the American Heart Association, and is a lifetime member of the Texas Medical Foundation. Dr. Hilmy is the recipient of the American Heart Association Thomas Robertson Award and Heart of Gold Award in recognition of his role in the development of numerous cardiac programs in the Rio Grande Valley. Dr. Hilmy is also a licensed Nuclear Cardiologist.
Dr. Hilmy’s research included the evaluation of the role of hydrochlorothiazide in altering vascular intra-cellular sodium content in hypertension, the evaluation of newer calcium channel blockers in the management of cardiomyopathy, and the role of carotid stenting in the management of carotid stenosis.
Dr. Hilmy is the Chief of Cardiology and Director of the Cardiac Catheterization Laboratory at Harlingen Medical Center. He also serves as the Chief of the Medical Executive Committee and Chief of the Credentials committee at the same institution. He previously served as the Chief of Medicine, Chief of Cardiology, and Director of the Cardiac Catheterization Laboratory at Rio Grande Regional Hospital and McAllen Heart Hospital. Dr. Hilmy is also an instructor for aneurysm repair at Medtronic. Dr. Hilmy is accepting new patients and has staff privileges at: